The 6-item Rowland Universal Dementia Assessment Scale (RUDAS) is a simple, portable multicultural scale for detecting dementia. Items address executive function, praxis, gnosis, recent memory, and category fluency. It can be directly translated to other languages, without the need to change the structure or the format of any item. The RUDAS was administered to 151 consecutive, consenting, culturally diverse community-dwelling subjects of mean age 77 years, 72% of whom had an informant. Subjects were recruited from various clinics and healthcare programs. All were evaluated for cognitive impairment in a blinded manner by experienced clinicians in geriatric medicine. According to Diagnostic and Statistical Manual of Mental Disorder-IV criteria, 40% of the subjects were normal, 22% had cognitive impairment (not otherwise specified), and 38% had dementia; 84% of whom had questionable or mild dementia. In the primary analysis (normal subjects vs. those with definite dementia), the RUDAS accurately identified dementia, with an area under the receiver operating characteristic curve of 0.94 (95% confidence interval, 0.88-0.97); at the published cut point of less than 23/30, the positive likelihood ratio (LR) for dementia diagnosis was 8.77, and the negative likelihood ratio was 0.14. Additional analyses showed that the RUDAS performed less well when subjects with cognitive impairment (not dementia) were included. In all logistic regression models, the RUDAS was an independent predictor of dementia (odds ratio 0.64, 95% confidence interval, 0.52-0.79, primary analysis model), after adjusting for age, sex, years of education, and cultural diversity, none of which were independent predictors. Further studies are needed across the full spectrum of early dementia syndromes, and in additional ethnic minority groups.
T he 6-item Rowland Universal Dementia Assessment Scale (RUDAS) was developed in the southwest of Sydney, Australia, where 40% of the population are born in culturally and linguistically diverse (CALD) countries. 1 It is easy to administer, and can be directly translated to other languages, without the need to change the structure or the format of any item. Both the interrater [intraclass correlation coefficient (ICC) 0.99] and the test-retest (ICC 0.98) reliabilities are very high. 1 The RUDAS was initially validated in 90 older, community-dwelling persons, in whom the diagnostic accuracy for detecting dementia based on Diagnostic and Statistical Manual of Mental Disorder-IV (DSM-IV) criteria 2 was excellent, with an area under the receiver operating characteristic (ROC) curve of 0.95 [95% confidence interval (CI) 0.88-0.98]. 1 Although most persons with dementia suffer with mild to moderate disease, the validation sample was overrepresented with subjects with severe dementia. Like the RUDAS, most neuropsychologic instruments measuring cognition will discriminate accurately between normal subjects and those with advanced dementia. The more pertinent issue is how well these instruments perform in subjects with earlier stages of disease.
Although available treatments for early dementia are few and offer only limited benefits, many new treatments are in early development. 3 For example, in Alzheimer disease, an improved understanding of the pathogenesis has led to the identification of numerous therapeutic targets designed to alter the accumulation of b-amyloid and tau. 3 As the underlying pathology in Alzheimer disease and in other neurodegenerative dementias precedes the onset of clinical symptoms, identifying the disease at an early stage is important, because treatments to prevent or slow the disease are likely to be more effective than those attempting to reverse it. 3 Early dementia may be particularly difficult to diagnose in older persons from CALD countries. 4 This is an important health issue in many countries, because the prevalence of dementia in people from diverse cultures is likely to increase substantially, due to the rapidly ageing population and high levels of international migration. 5 Therefore, a simple, portable method for detecting dementia that is sensitive to early disease and valid across cultures is needed. In this paper, we report the validity of the RUDAS in a multicultural cohort of older persons with mild to moderate dementia.
METHODS

Study Participants
The study involved 151 older, community-dwelling persons living in Melbourne (N = 75) and Adelaide (N = 76), Australia. Between September 2005 and November 2006, 78 subjects (51.7%) were recruited from 3 memory clinics, 18 (11.9%) from an Alzheimer disease Copyright r 2009 by Lippincott Williams & Wilkins respite program, and 55 (36.4%) from other clinics. Most referrals to the memory clinics were made by general practitioners (N = 32), the subjects or their relatives (N = 15), or the community-based aged care team (N = 10). Subjects with normal cognition were enrolled from a fall and balance clinic and a community rehabilitation service in Melbourne, and from community therapy and rehabilitation centers, day respite programs, and Alzheimer disease carer groups in Adelaide. Consecutive, consenting subjects were enrolled, provided they were not delirious and had no severe visual, hearing, or physical impairment. Consent was obtained from the subject, or the next of kin or guardian when the subject was cognitively impaired. The study protocol was approved by the Melbourne Health Research Directorate and the Research Ethics Committee of the Royal Adelaide Hospital.
RUDAS Items
The RUDAS has 6 items, administered in the following order, for a maximum score of 30. 1 1. 4-item grocery recall (tea, cooking oil, eggs, and soap): each correct response scores 2 points (maximum of 8 points, 6 if a prompt is used). 2. Body orientation: although 8 commands involve the identification of different body parts (both the subject's and the examiner's), only 5 correct responses are needed for a maximum score of 5 points. 3. Fist-palm alternation task: the task is rated as normal (2 points), partially adequate (1 point), or failed (0 points). 4. Cube copying: 3 components are needed for a maximum score of 3 points (based on a square, all internal lines drawn, and all external lines drawn). 5. Crossing the road: looking for traffic and an additional safety response each score 2 points without a prompt. 6. Animal generation: although a minute is allocated to name as many animals as possible, only 8 are needed for a maximum score of 8 points.
Procedure
In both Melbourne and Adelaide, potential subjects attending the memory clinics underwent routine clinical assessment, after which they were invited to participate in the study. According to the usual memory clinic protocol, all study subjects had their cognition assessed by a geriatrician, an aged care psychiatrist, or an advanced trainee in geriatric medicine, before they were recruited. They were then seen by a research assistant at the clinic, their home, or other suitable location, depending on preference. In Melbourne, most subjects with normal cognition were recruited from the aforementioned clinic or service, and afterward seen by a geriatrician and a research assistant. In Adelaide, subjects with normal cognition were enrolled from various community programs (detailed above), and assessed on site by an advanced trainee in geriatric medicine and a research assistant. Professional health interpreters were used when necessary.
Cognitive impairment (not otherwise specified), henceforth called cognitive impairment not dementia (CIND), and dementia were diagnosed by a geriatrician, an aged care psychiatrist, or an advanced trainee in geriatric medicine, according to DSM-IV criteria. They also rated the severity of dementia using the Clinical Dementia Rating (CDR) Scale. 6 The RUDAS was administered by a research assistant in a blinded and independent manner. All subjects were screened for noncognitive disorders that might affect the RUDAS score, including vision and hearing impairment, anxiety, depression, musculoskeletal disorders, fatigue, dysarthria, and dysphasia (performance factors). The research assistant also administered the Modified Barthel Index (MBI), 7 the Lawton Instrumental Activities of Daily Living Scale (Lawton), 8 and the 15-point Geriatric Depression Scale. 9
Sample Size
The calculation of the sample size was based on the standard error (SE) for the area under a receiver operating characteristic curve (AUC). This method varies the sample size until a sufficiently small SE is achieved. The calculations are complex, and we used a web-based calculator (www. anaesthetist.com/mnm/stats/roc/#stderr) to determine the SE, assuming an AUC of 0.9 for the RUDAS. If normal subjects (N = 60) and those with definite dementia (N = 58) are included, the SE for the AUC is small at 0.03. The website also discusses the rationale underlying this method of sample size calculation.
Statistical Analyses
We used ROC curve analysis 10 to measure the accuracy of the RUDAS for dementia diagnosis. The sensitivity, specificity, positive likelihood ratio (LR), and negative LR of the RUDAS were calculated based on the published cut point of less than 23/30. 1 LRs incorporate both the sensitivity and specificity of a test (at a particular cut point) to directly estimate the effect of the test on the odds of having a disease. The positive LR measures the increase in the odds of a disease when a test is positive; whereas the negative LR measures the decrease in the odds when a test is negative.
In cross-sectional samples such as ours, it is difficult to categorize subjects with CIND. Although 10% to 15% progress to Alzheimer disease each year, a few improve, some remain static, and others go on to develop non-Alzheimer disease dementias. 11 To minimize misclassification bias, our primary analyses included only subjects with normal cognition and those with definite dementia. We evaluated the effects of including subjects with CIND both in the normal and dementia groups in 2 sensitivity analyses. In a third sensitivity analysis, we evaluated the effect of comparing normal subjects with those with CIND.
We used multivariate logistic regression to model the probability of dementia. Independent predictors (P<0.05) from our dataset were included in the final model, together with the study variable (total RUDAS score), CALD status, and risk factors for dementia in the literature (age, sex, and education). 12, 13 We measured the degree of confounding exerted by a variable by calculating the change in the value of the parameter estimate for the study factor (RUDAS score) when the variable was excluded from the analysis. A 10% or greater change in the parameter estimate was needed for a potential confounder to be retained in the model. Variables tested in multivariate models were plausible univariate predictors of dementia in our dataset (P<0.05). Fisher exact tests were used to compare dichotomous variables between subject groups. ROC curve analysis was performed using MedCalc for Windows version 9.3.0.0 (MedCalc Software, Mariakerke, Belgium). SAS software (version 9.1, SAS Institute Inc, Cary, NC) was used for all other analyses.
RESULTS
Subject Characteristics
Seventy-five subjects were seen in Melbourne and 76 in Adelaide. More participants in Melbourne had dementia and CIND (P = 0.046). On the basis of DSM-IV criteria, 58 of 151 (38.4%) subjects had dementia, 60 (39.7%) were normal, and 33 (21.9%) had CIND. Of those with dementia, 25.9% had questionable dementia according to the CDR, whereas 58.5%, 12.1%, and 3.5% had mild, moderate, and severe dementia, respectively. Eighty-nine (58.9%) of 151 subjects were accompanied by an informant. A further 19 informants (12.6%) were contacted by phone, leaving 43 (28.5%) subjects without an informant.
Sixty-five of 151 (43.0%) subjects were born in CALD countries. Of those, 57 (87.8%) were born in one of 10 European CALD countries, 3 (4.6%) in the Middle East, 3 (4.6%) in Africa, 1 (1.5%) in Asia, and 1 (1.5%) in South America. Of those born in English-speaking countries, 29.1% had dementia, 45.3% were normal, and 25.6% had CIND. The corresponding percentages in the European CALD subgroup, 50.9%, 31.6%, and 17.5%, were significantly different from the English-speaking subgroup (P = 0.03), with more subjects suffering with dementia. Table 1 shows the characteristics of the 151 subjects by cognitive status (normal, CIND, and dementia).
ROC Curves and LRs
In the primary analysis (normal subjects vs. those with definite dementia), the AUC was high at 0.94 (95% CI, 0.88-0.97) ( Fig. 1) . At the published cut point of less than 23/30, the sensitivity of the RUDAS for dementia diagnosis was 87.7% (95% CI, 76.3%-94.9%), whereas the specificity was 90.0% (95% CI, 79.5%-96.2%). RUDAS scores less than 23/ 30 multiply the pretest odds of dementia by about 9 (positive LR 8.77), whereas higher scores divide the pretest odds by about 7 (negative LR 0.14). Table 2 also shows the corresponding results of the 3 sensitivity analyses. 0.0 0.0 3.5 *Missing data: living alone (dementia 1); no available carer (dementia 1); years in Australia (normal 20, CIND 5, dementia 12); years of education (normal 1, CIND 1, dementia 8); type of education (CIND 2, dementia 4); literate in preferred language (dementia 1); MBI score (dementia 1); Lawton score (dementia 1); GDS score (normal 1, CIND 1, dementia 2); GDS score 5 or more (normal 1, CIND 1, dementia 2); RUDAS (dementia 1).
wFactors potentially affecting performance on the RUDAS include visual or hearing impairment, psychiatric disease (depression, anxiety, or psychosis), dysarthria or dysphasia, neurologic disease, musculoskeletal disorders, fatigue, and use of certain medications.
CALD indicates Culturally and linguistically diverse; CDR, Clinical Dementia Rating Scale; CIND, Cognitive impairment not dementia; GDS, 15-point Geriatric Depression Scale (range: 0-15, scores of 5 or more suggest depression); Lawton, Lawton Instrumental Activities of Daily Living Scale (range: 0-8, higher scores indicate better function); MBI, Modified Barthel Index (range: 0-20, higher scores indicate better function); Q1-Q3, Interquartile range; literate in preferred language = ability to read and write at any time in the preferred language; RUDAS, Rowland Universal Dementia Assessment Scale (range: 0-30, higher scores indicate better cognitive function).
Logistic Regression Analysis
The univariate predictors of dementia were total RUDAS score, age, presence of an informant, total Lawton score (all P<0.001), years of education, total MBI score (both P<0.01), CALD status (P = 0.01), hearing impairment and sex (both P = 0.03).
The final logistic regression analysis for dementia diagnosis (primary analysis, excluding subjects with CIND) identified only 2 significant variables: the RUDAS score and the Lawton score (Table 3 ). In preliminary models, nonsignificant variables were removed (based on the value of the Wald w 2 ) in the following order: presence of an informant, total MBI score, and hearing impairment. Although age, sex, years of education, and CALD status were included in the final model because they were known risk factors for dementia (and we were studying an instrument for use in multicultural populations), none were significant predictors or confounders in our dataset. Tables  4 and 5 show the effects of classifying subjects with CIND as having dementia, and as normal, respectively (sensitivity analyses).
Subjects With Questionable and Mild Dementia Based on CDR
On the basis of CDR, 48 subjects were normal, whereas 57 and 37 had questionable and mild dementia, respectively. All 48 normal subjects were also normal on DSM-IV criteria. Of the 57 with questionable dementia (CDR), 12 were normal, 30 had CIND, and 15 had dementia (DSM-IV). Of the 37 with mild dementia (CDR), 3 had CIND and 34 had dementia (Fisher exact test for 3-by-3 table, P<0.0001).
If only normal subjects and those with questionable and mild dementia are considered (based on the CDR), the AUC remains moderately high at 0.88 (95% CI, 0.82-0.93). At the published cut point of less than 23/30, the sensitivity of the RUDAS for the diagnosis of questionable or mild dementia was 63.4% (95% CI, 52.8%-73.2%), whereas the specificity was 93.8% (95% CI, 82.8%-98.6%) (data not shown in Table) . The positive LR was 10.15 and the negative LR was 0.39.
In the logistic regression model (N = 136), the total RUDAS score remained highly significant (P<0.0001), with an odds ratio of 0.67 (95% CI, 0.56-0.81), after adjusting for age, sex, CALD status, years of education, and total Lawton score (none of which were significant) (data not shown in Table) . 
DISCUSSION
The 6-item RUDAS is easy to administer, taking about 10 minutes to complete. It is scored out of 30, with scores below 23 suggesting dementia. Items address executive function, praxis, gnosis, recent memory and category fluency, and the diverse response formats (verbal, nonverbal, written, and praxic) allow more comprehensive assessment of overall cognition than other commonly used tools. 1 Although the diagnostic accuracy of the RUDAS for detecting dementia in the initial validation sample was excellent (AUC 0.95), almost 80% of subjects with dementia had moderate or severe disease. 1 An extreme group design, where most subjects are clearly normal or very impaired, is a necessary first step in establishing the validity of a new scale. If the scale cannot discriminate between 2 extreme samples, then it is probably useless in all other regards. 14 However, in normal clinical practice, the RUDAS will generally not be used in this way, because most persons with dementia suffer with disease of milder severity. Hence, the more pertinent issue is whether the RUDAS performs well in subjects with early dementia, particularly as evolving therapies, at least in Alzheimer disease, favor treatment in the earliest stages of disease. 3 In this paper, we show that the RUDAS performs well in subjects with earlier stages of disease. In our primary analysis, including only normal subjects and those with definite dementia (based on DSM-IV criteria), the AUC was high at 0.94. Both the AUC and the sensitivity (88% at a cut point of <23/30) were similar to the findings in the initial validation sample (0.95 and 89%), where most subjects with dementia had moderate or severe disease, 1 suggesting that the RUDAS is a robust instrument that is responsive to mild disease. If it accurately detects mild dementia, then it will similarly detect more severe dementia. The specificity (90% at a cut point of <23/30) was lower than that in the initial validation sample (98%), an expected finding given that most instruments will falsely label more normal subjects as being mildly diseased than moderately or severely diseased. This issue likely overrides the effects of younger age and better education (in the present study), which by themselves would be expected to move the specificity to a higher value.
The positive LR of almost 9 effectively ruled-in dementia when the RUDAS score was less than 23, whereas the negative LR of 0.14 helped to rule-out disease at scores higher than 22. Although the positive and the negative LR are both useful measures, the former is probably more intuitive to most clinicians (ie, if you score badly and have a high positive LR you are likely to have dementia). In our sample, the RUDAS was not influenced by age, sex, education, and CALD status. Although age, sex, years of education, and CALD status were included in all logistic regression models because they were known risk factors for dementia (and we were studying an instrument for use in multicultural populations), none were significant predictors or confounders in our dataset. Only the Lawton score independently predicted dementia. However, some of the tasks in the Lawton scale are difficult for physical reasons (eg, shopping and housekeeping). In fact, entering a musculoskeletal or a fatigue variable (performance factors) into the logistic model removed some of the effect of the Lawton score (making it nonsignificant). The RUDAS also performs well when the sample is restricted to normal subjects and those with questionable and mild dementia (based on CDR criteria), providing further support of its validity in early disease.
Mild cognitive impairment (MCI) describes a state of cognitive functioning that is below defined norms, yet falls short of dementia in severity. It exists across a cognitive continuum with borders that are difficult to define precisely. 15 Longitudinal studies have shown that subjects with MCI progress to a clinical diagnosis of Alzheimer disease at approximately 10% to 15%/y. 11 Not all subjects with MCI go on to develop Alzheimer disease; a few improve, some remain static, whereas others progress to dementias other than Alzheimer disease. 11 The concept of MCI as a transitional state between normal ageing and dementia is gaining wider acceptance, because it defines a window in which future therapies may be most valuable, 3, 11 and because it provides clinicians and patients with a diagnostic label to be treated seriously, 11 without the stigmatization often associated with a diagnosis of dementia. A number of subtypes of MCI are recognized, including CIND, a subtype developed by the population-based Canadian Study of Health and Ageing. 16 The CIND grouping is the most broad-based and inclusive of the entities within MCI, because it has virtually no exclusions and allows a classification of all subjects with MCI. 15 Population-based studies have found MCI, and hence CIND, to be a heterogenous entity with a far wider range of outcomes than in the clinical setting, 17 such as a memory clinic, where a higher proportion are likely to have early dementia. Our data are consistent with this view. When subjects with CIND were included among those suffering with dementia, the AUC of 0.88 and the positive LR of 7.22 (Table  2) were not too different to those fulfilling clear diagnostic criteria for dementia (AUC of 0.94 and positive LR 8.77). Even a comparison of normal subjects with those categorized as having CIND gives an AUC of 0.77 and a positive LR of 4.55 (Table 2 ). However, because CIND is a heterogeneous entity with a wide range of outcomes and no clear techniques to determine which CIND patients will develop Alzheimer disease or other dementias, 11 our sensitivity analyses and tentative conclusions must be considered exploratory and treated with caution.
Our study has several limitations. First, a majority of our CALD subjects were born in one of 10 European CALD countries (particularly Greece and Italy), partly reflecting the demographics of Melbourne and Adelaide, but nonetheless reducing the generalizability of our findings. Only 3 subjects were born in the Middle East and 1 in Asia. One reason may be the underutilization of dementia services by minority ethnic groups, many of which do not prioritize dementia as a health problem in the face of more pressing issues. 18 Language barriers, belief systems, lower health literacy on the part of caregivers, and lack of culturally appropriate care all play important roles. 19 A second limitation is that we cannot evaluate the RUDAS across the full spectrum of early dementia syndromes, due to insufficient numbers of subjects. Finally, in the absence of longitudinal follow-up and brain pathology, we may have misclassified some subjects as having dementia, particularly as more subjects born in CALD countries were diagnosed with the disease, compared with those born in English-speaking countries (50.9% vs. 29.1%). The diagnosis of dementia may be problematic in culturally heterogeneous populations, 20 given that there is no gold standard for diagnosis. However, all decisions were based on DSM-IV criteria, which have the advantage of broad acceptance and good reproducibility, 21 72% of subjects had informants, and all were assessed by experienced clinicians, making misclassification unlikely. We addressed the differences in dementia diagnosis by country of birth by forcing CALD status into all logistic regression models.
In summary, our data suggest that the RUDAS has excellent concurrent criterion validity in subjects with early dementia. It has good construct and content validity, and is easy to administer, taking about 10 minutes to complete. 1 The RUDAS does not seem to be influenced by age, sex, or CALD status, and our earlier work suggests that all items can be directly translated to other languages, without the need to change the structure or the format of any item. However, further studies are needed across the full spectrum of early dementia syndromes, and in additional ethnic minority groups.
